Life Sciences

Below are all our articles under the above category.

ASX health stocks

Which ASX health stocks might get FDA approval in 2023?

It is the dream of many ASX health stocks and their investors for their company’s device or drug to be…


Immutep (ASX: IMM) has massive potential!

Immutep (ASX: IMM) develops immunotherapeutic products for the treatment of cancer and autoimmune diseases. It has several product candidates at…


Actinogen Medical (ASX: ACW): Good news on phase 2 trials can catapult this stock

Working on a new drug for Alzheimer’s disease  Actinogen Medical (ASX: ACW) is a Sydney-based biotechnology company working on finding…

Telix Pharmaceuticals

Can Telix Pharmaceuticals rise to become the next CSL by 2025?

Biotech company Telix Pharmaceuticals (ASX: TLX) completed the first commercial quarter of its prostate cancer imaging product Illuccix. This follows…


Dimerix (ASX:DXB): Good news on Phase 3 trials can catapult this stock

  Stay up-to-date on ASX-listed stocks!   GET A 30-DAY FREE TRIAL     Dimerix has lots of irons in…

Pfizer delivers the goods on a COVID-19 vaccine

Pfizer delivers the goods on a COVID-19 vaccine

10 November 2020 One of the reasons investors can be optimistic about 2021 is the speed with which the first…